| Samantha Beth King, AUD | |
|
4855 W Centre Ave, Portage, MI 49024-4686 | |
| (269) 372-2709 | |
| Not Available |
| Full Name | Samantha Beth King |
|---|---|
| Gender | Female |
| Speciality | Qualified Audiologist |
| Experience | 17 Years |
| Location | 4855 W Centre Ave, Portage, Michigan |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1679752042 | NPI | - | NPPES |
| 640A312270 | Other | MI | BCBS |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 231H00000X | Audiologist | 1601000471 (Michigan) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Bronson Methodist Hospital | 0244148633 | 598 |
News Archive
Few medical investigations have had the impact of the Framingham Heart Study. This study, started in 1948, was designed as a cohort, observational study of cardiovascular disease, then recognized as a growing health threat but now has emerged as much more. The Framingham Heart study came to revolutionize thinking about cardiovascular disease, change the study of epidemiology, and even force the biostatistics community to develop multivariate analysis.
In the United States, income inequality has steadily increased over the last several decades. Given widening inequities, health care leaders have been concerned about the health outcomes of older Americans who experience poverty, particularly because prior studies have shown a strong link between socioeconomic status and health.
Bioniche Life Sciences Inc., a research-based, technology-driven Canadian biopharmaceutical company, today announced that a second Phase III clinical trial with Urocidin in non-muscle-invasive bladder cancer is being discontinued.
The controversy around mammography emphasizes that the best decision on screening is made by a woman and her health care provider. Balancing a woman's individual medical history, risks, and concern level about breast cancer is a decision at the individual level using guidelines as a guide and not as something fixed in concrete," said Dr. Jane L. Delgado, President and CEO of the National Alliance for Hispanic Health, the nation's leading Hispanic health advocacy group.
A team led by a Northwestern University biomedical engineer has found that combining novel optical technologies with a common colon cancer screening test may allow doctors to more accurately detect the presence of colon cancer, particularly in women.
› Verified 1 days ago
| Provider Name | Bronson Methodist Hospital |
|---|---|
| Provider Type | Part B Supplier - Clinic/group Practice |
| Provider Identifiers | NPI Number: 1417961137 PECOS PAC ID: 0244148633 Enrollment ID: O20031208000832 |
News Archive
Few medical investigations have had the impact of the Framingham Heart Study. This study, started in 1948, was designed as a cohort, observational study of cardiovascular disease, then recognized as a growing health threat but now has emerged as much more. The Framingham Heart study came to revolutionize thinking about cardiovascular disease, change the study of epidemiology, and even force the biostatistics community to develop multivariate analysis.
In the United States, income inequality has steadily increased over the last several decades. Given widening inequities, health care leaders have been concerned about the health outcomes of older Americans who experience poverty, particularly because prior studies have shown a strong link between socioeconomic status and health.
Bioniche Life Sciences Inc., a research-based, technology-driven Canadian biopharmaceutical company, today announced that a second Phase III clinical trial with Urocidin in non-muscle-invasive bladder cancer is being discontinued.
The controversy around mammography emphasizes that the best decision on screening is made by a woman and her health care provider. Balancing a woman's individual medical history, risks, and concern level about breast cancer is a decision at the individual level using guidelines as a guide and not as something fixed in concrete," said Dr. Jane L. Delgado, President and CEO of the National Alliance for Hispanic Health, the nation's leading Hispanic health advocacy group.
A team led by a Northwestern University biomedical engineer has found that combining novel optical technologies with a common colon cancer screening test may allow doctors to more accurately detect the presence of colon cancer, particularly in women.
› Verified 1 days ago
| Provider Name | Bronson Battle Creek Hospital |
|---|---|
| Provider Type | Part B Supplier - Clinic/group Practice |
| Provider Identifiers | NPI Number: 1093119638 PECOS PAC ID: 0547173478 Enrollment ID: O20041103000774 |
News Archive
Few medical investigations have had the impact of the Framingham Heart Study. This study, started in 1948, was designed as a cohort, observational study of cardiovascular disease, then recognized as a growing health threat but now has emerged as much more. The Framingham Heart study came to revolutionize thinking about cardiovascular disease, change the study of epidemiology, and even force the biostatistics community to develop multivariate analysis.
In the United States, income inequality has steadily increased over the last several decades. Given widening inequities, health care leaders have been concerned about the health outcomes of older Americans who experience poverty, particularly because prior studies have shown a strong link between socioeconomic status and health.
Bioniche Life Sciences Inc., a research-based, technology-driven Canadian biopharmaceutical company, today announced that a second Phase III clinical trial with Urocidin in non-muscle-invasive bladder cancer is being discontinued.
The controversy around mammography emphasizes that the best decision on screening is made by a woman and her health care provider. Balancing a woman's individual medical history, risks, and concern level about breast cancer is a decision at the individual level using guidelines as a guide and not as something fixed in concrete," said Dr. Jane L. Delgado, President and CEO of the National Alliance for Hispanic Health, the nation's leading Hispanic health advocacy group.
A team led by a Northwestern University biomedical engineer has found that combining novel optical technologies with a common colon cancer screening test may allow doctors to more accurately detect the presence of colon cancer, particularly in women.
› Verified 1 days ago
| Provider Name | Constance Brown Hearing And Speech Center |
|---|---|
| Provider Type | Part B Supplier - Clinic/group Practice |
| Provider Identifiers | NPI Number: 1750482840 PECOS PAC ID: 0749383099 Enrollment ID: O20070307000404 |
News Archive
Few medical investigations have had the impact of the Framingham Heart Study. This study, started in 1948, was designed as a cohort, observational study of cardiovascular disease, then recognized as a growing health threat but now has emerged as much more. The Framingham Heart study came to revolutionize thinking about cardiovascular disease, change the study of epidemiology, and even force the biostatistics community to develop multivariate analysis.
In the United States, income inequality has steadily increased over the last several decades. Given widening inequities, health care leaders have been concerned about the health outcomes of older Americans who experience poverty, particularly because prior studies have shown a strong link between socioeconomic status and health.
Bioniche Life Sciences Inc., a research-based, technology-driven Canadian biopharmaceutical company, today announced that a second Phase III clinical trial with Urocidin in non-muscle-invasive bladder cancer is being discontinued.
The controversy around mammography emphasizes that the best decision on screening is made by a woman and her health care provider. Balancing a woman's individual medical history, risks, and concern level about breast cancer is a decision at the individual level using guidelines as a guide and not as something fixed in concrete," said Dr. Jane L. Delgado, President and CEO of the National Alliance for Hispanic Health, the nation's leading Hispanic health advocacy group.
A team led by a Northwestern University biomedical engineer has found that combining novel optical technologies with a common colon cancer screening test may allow doctors to more accurately detect the presence of colon cancer, particularly in women.
› Verified 1 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Samantha Beth King, AUD 601 John St # 42, Kalamazoo, MI 49007-5341 Ph: () - | Samantha Beth King, AUD 4855 W Centre Ave, Portage, MI 49024-4686 Ph: (269) 372-2709 |
News Archive
Few medical investigations have had the impact of the Framingham Heart Study. This study, started in 1948, was designed as a cohort, observational study of cardiovascular disease, then recognized as a growing health threat but now has emerged as much more. The Framingham Heart study came to revolutionize thinking about cardiovascular disease, change the study of epidemiology, and even force the biostatistics community to develop multivariate analysis.
In the United States, income inequality has steadily increased over the last several decades. Given widening inequities, health care leaders have been concerned about the health outcomes of older Americans who experience poverty, particularly because prior studies have shown a strong link between socioeconomic status and health.
Bioniche Life Sciences Inc., a research-based, technology-driven Canadian biopharmaceutical company, today announced that a second Phase III clinical trial with Urocidin in non-muscle-invasive bladder cancer is being discontinued.
The controversy around mammography emphasizes that the best decision on screening is made by a woman and her health care provider. Balancing a woman's individual medical history, risks, and concern level about breast cancer is a decision at the individual level using guidelines as a guide and not as something fixed in concrete," said Dr. Jane L. Delgado, President and CEO of the National Alliance for Hispanic Health, the nation's leading Hispanic health advocacy group.
A team led by a Northwestern University biomedical engineer has found that combining novel optical technologies with a common colon cancer screening test may allow doctors to more accurately detect the presence of colon cancer, particularly in women.
› Verified 1 days ago
Dr. Brittany Lynn Finkler, AU.D Audiologist Medicare: Medicare Enrolled Practice Location: 576 Romence Rd Ste 121, Portage, MI 49024 Phone: 269-324-0555 Fax: 269-324-2482 | |
Mrs. Kristy Kay Deiters, AU.D. Audiologist Medicare: Not Enrolled in Medicare Practice Location: 576 Romence Rd, Ste. 121, Portage, MI 49024 Phone: 269-324-0555 Fax: 269-324-2482 | |
Moriah Steele, AUD Audiologist Medicare: Medicare Enrolled Practice Location: 3850 Glenkerry Ct, Portage, MI 49024 Phone: 269-535-0565 | |
Hac Hearing Aid Centers Of America Inc Audiologist Medicare: Not Enrolled in Medicare Practice Location: 1350 W Centre Ave, Suite 105, Portage, MI 49024 Phone: 269-324-0301 Fax: 269-324-2733 | |
Dr. Amy Lynn Boyce, AU.D. Audiologist Medicare: Accepting Medicare Assignments Practice Location: 1350 W Centre Ave Ste 105, Portage, MI 49024 Phone: 269-324-0301 | |
Lynette Marie Burkett, AUD Audiologist Medicare: Accepting Medicare Assignments Practice Location: 3850 Glenkerry Ct, Portage, MI 49024 Phone: 269-327-7200 |